0001493152-23-043750.txt : 20231205
0001493152-23-043750.hdr.sgml : 20231205
20231205172019
ACCESSION NUMBER: 0001493152-23-043750
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231201
FILED AS OF DATE: 20231205
DATE AS OF CHANGE: 20231205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tapolczay David
CENTRAL INDEX KEY: 0001991789
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41245
FILM NUMBER: 231467633
MAIL ADDRESS:
STREET 1: 32 CROUCH HALL LANE
CITY: ST. ALBANS
STATE: X0
ZIP: AL3 7EU
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CONDUIT PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0001896212
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 873272543
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4995 MURPHY CANYON ROAD, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92123
BUSINESS PHONE: (760) 471 8536
MAIL ADDRESS:
STREET 1: 4995 MURPHY CANYON ROAD, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92123
FORMER COMPANY:
FORMER CONFORMED NAME: Murphy Canyon Acquisition Corp.
DATE OF NAME CHANGE: 20211130
4
1
ownership.xml
X0508
4
2023-12-01
0
0001896212
CONDUIT PHARMACEUTICALS INC.
CDT
0001991789
Tapolczay David
4995 MURPHY CANYON ROAD, SUITE 300
SAN DIEGO
CA
92123
1
0
0
0
0
Stock Option (Right to Buy)
5.51
2023-12-01
4
A
0
298179
5.51
A
2033-11-30
Common Stock
298179
298179
D
Represents Options to purchase common stock, granted under the Company's 2023 Stock Incentive Plan.
The stock options were granted with a ten-year term and vest 25% on each of the first four anniversaries of the vesting commencement date, which is September 22, 2023.
/s/ David Tapolczay
2023-12-05